Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27

Benzinga · 2d ago
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.